×
About 4,758 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  1,506 results

Real-World Considerations of Candidacy for Biologics in Hidradenitis Suppurativa.
https://doi.org/10.1007/s40257-022-00711-1
American Journal of Clinical Dermatology; Shih T, De D et. al.

Aug 6th, 2022 - Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory skin disease that is often recalcitrant to multiple treatments. In determining biologic candidacy for patients with HS, we propose a paradigm shift away from Hurley staging and t...

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04988308

Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...

Methylated miRNAs may serve as potential biomarkers and therapeutic targets for hidrade...
https://doi.org/10.1111/jdv.18473
Journal of the European Academy of Dermatology and Venere... Radhakrishna U, Uppala R et. al.

Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory disease influenced by genetics, non-genetic, and environmental factors that modulate miRNA expression. Currently, no miRNA data are available for HS. In this study, we profiled DNA methylatio...

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
https://clinicaltrials.gov/ct2/show/NCT05384249

Aug 4th, 2022 - Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity. Izokibep has been investigated in non-clinical and clinical studies including healthy subjects and patients w...

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04242446

Aug 3rd, 2022 - The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  138 results

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04988308

Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
https://clinicaltrials.gov/ct2/show/NCT05384249

Aug 4th, 2022 - Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity. Izokibep has been investigated in non-clinical and clinical studies including healthy subjects and patients w...

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04242446

Aug 3rd, 2022 - The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor...
https://clinicaltrials.gov/ct2/show/NCT05139602

Aug 2nd, 2022 - Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. Despit...

Control of Hidradenitis Suppurativa of the Underarms After Combination Deroofing and Laser
https://clinicaltrials.gov/ct2/show/NCT05484674

Aug 2nd, 2022 - Hidradenitis Suppurativa (HS) is a chronic inflammatory disorder characterized by follicular occlusion and rupture which leads to scar and sinus tract formation. Given that medical treatments for HS primarily target inflammation, a multifaceted ap...

see more →

News  249 results

Study eyes characteristics of pediatric patients with hidradenitis suppurativa
https://www.mdedge.com/dermatology/article/256280/pediatrics/study-eyes-characteristics-pediatric-patients-hidradenitis
Doug Brunk

Jul 14th, 2022 - INDIANAPOLIS – Nearly two-thirds of pediatric patients with hidradenitis suppurativa (HS) met criteria for obesity at the time of their diagnosis, and 36% had acne, in a study presented at the annual meeting of the Society for Pediatric Dermatolog.

Study Eyes Characteristics of Pediatric Patients With Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/977227

Jul 14th, 2022 - INDIANAPOLIS — Nearly two-thirds of pediatric patients with hidradenitis suppurativa (HS) met criteria for obesity at the time of their diagnosis, and 36% had acne, in a study presented at the annual meeting of the Society for Pediatric Dermatolog...

Can dietary tweaks improve some skin diseases?
https://www.mdedge.com/dermatology/article/256028/acne/can-dietary-tweaks-improve-some-skin-diseases
Kathleen Doheny

Jul 5th, 2022 - Since 1950, the terms “diet and skin” in the medical literature have markedly increased, said Vivian Shi, MD associate professor of dermatology at the University of Arkansas for Medical Sciences, Little Rock, who talked about nutritional approache.

CO2 Laser Excision Therapy for Hidradenitis Suppurativa Shows No Keloid Risk
https://www.medscape.com/viewarticle/971955

Apr 11th, 2022 - BOSTON ― The use of carbon dioxide (CO2) laser excision therapy for hidradenitis suppurativa (HS) is not associated with an increased risk for the development of keloids, new research shows. "With keloids disproportionately affecting Black and oth...

Therapeutic Considerations in Adults With Hidradenitis Suppurativa
https://www.mdedge.com/dermatology/article/253285/hidradenitis-suppurativa/therapeutic-considerations-adults-hidradenitis
Jennifer Hsiao, MD

Apr 1st, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent boils, abscesses, and nodules that can progress to narrow channels that form under the skin. An estimated 1%-4% of the US population has the conditio.

see more →

Patient Education  8 results see all →